SYNAGEL Trademark

Trademark Overview

On Friday, June 4, 2021, a trademark application was filed for SYNAGEL with the United States Patent and Trademark Office. The USPTO has given the SYNAGEL trademark a serial number of 90754277. The federal status of this trademark filing is SU - REGISTRATION REVIEW COMPLETE as of Wednesday, July 24, 2024. This trademark is owned by Mjalli Investment Group, Inc.. The SYNAGEL trademark is filed in the Pharmaceutical Products category with the following description:

Topical analgesics
synagel

General Information

Serial Number90754277
Word MarkSYNAGEL
Filing DateFriday, June 4, 2021
Status819 - SU - REGISTRATION REVIEW COMPLETE
Status DateWednesday, July 24, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 29, 2022

Trademark Statements

Goods and ServicesTopical analgesics

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, August 26, 2021
Primary Code005
First Use Anywhere DateFriday, May 17, 2024
First Use In Commerce DateFriday, May 17, 2024

Trademark Owner History

Party NameMjalli Investment Group, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressHigh Point, NC 27265
Party NameMjalli Investment Group, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressHigh Point, NC 27265

Trademark Events

Event DateEvent Description
Tuesday, June 8, 2021NEW APPLICATION ENTERED
Thursday, August 26, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, February 22, 2022ASSIGNED TO EXAMINER
Thursday, February 24, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, March 9, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, March 29, 2022PUBLISHED FOR OPPOSITION
Tuesday, March 29, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 24, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Monday, November 21, 2022SOU TEAS EXTENSION RECEIVED
Monday, November 21, 2022SOU EXTENSION 1 FILED
Monday, November 21, 2022SOU EXTENSION 1 GRANTED
Wednesday, November 23, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, May 16, 2023SOU TEAS EXTENSION RECEIVED
Tuesday, May 16, 2023SOU EXTENSION 2 FILED
Tuesday, May 16, 2023SOU EXTENSION 2 GRANTED
Tuesday, November 21, 2023SOU TEAS EXTENSION RECEIVED
Thursday, May 18, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, November 21, 2023SOU EXTENSION 3 GRANTED
Tuesday, November 21, 2023SOU EXTENSION 3 FILED
Tuesday, May 21, 2024USE AMENDMENT FILED
Wednesday, June 26, 2024STATEMENT OF USE PROCESSING COMPLETE
Thursday, November 23, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, May 21, 2024TEAS STATEMENT OF USE RECEIVED
Wednesday, July 24, 2024ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Wednesday, July 24, 2024NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Wednesday, June 26, 2024CASE ASSIGNED TO INTENT TO USE PARALEGAL

Related Keywords

synagel analgesics topical